Advertisement

Structural Constraints in the Binding of Drugs to DNA

  • Michael Waring
Part of the Topics in Infectious Diseases book series (TIDIS, volume 1)

Abstract

Drugs which interact with DNA so as to impair its function as a template for nucleic acid synthesis are used in the chemotherapy of so wide a range of infectious and malignant diseases that it is hard to over-estimate their importance in present-day medical practice. In the treatment of such conditions as malaria, trypanosomiasis, schistosomiasis and various forms of cancer they occupy a central place, in some instances providing virtually the only means of effective chemotherapy. Even among the great number of compounds which are currently under active investigation as potentially useful antiviral agents there are many whose action derives from their ability to react with nucleic acids. Small wonder, then, that this topic has been the subject of numerous reviews in recent years (see, for example, Newton, 1970; Goldberg & Friedman, 1971; Waring, 1972; Corcoran & Hahn, 1974).

Keywords

Sedimentation Coefficient Nucleic Acid Synthesis Intercalate Agent Circular Molecule Trypanocidal Action 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. BAMFORD, D.G., D.F. BIGGS, M. DAVIS & E.W. PARNELL: Neuromuscular blocking properties of stereoisomeric androstane-3,17-bisquaternary ammonium salts. Brit. J. Pharmacol. Chemother. 30, 194–202 (1967)Google Scholar
  2. BAUER, W. & J. VINOGRAD: The interaction of closed circular DNA with intercalative dyes. I. The superhelix density of SV40 DNA in the presence and absence of dye. J. Mol. Biol. 33, 141–171 (1968)PubMedCrossRefGoogle Scholar
  3. BROOKES, P.: Reaction of alkylating agents with nucleic acids. In ‘Chemotherapy of Cancer’ (ed. P.A. PLATTNER), Elsevier, Amsterdam, pp 32–43 (1964)Google Scholar
  4. CHANDRA, P., A. DI MARCO, F. ZUNINO, A.M. CASAZZA, D. GERICKE, F. GIULIANI, C. SORANZO, R. THORBECK, A. GÓTZ, F. ARCAMONE & M. GHIONE: Influence of some antitumor antibiotics on viral neoplasia. Naturwissenschaften 59, 448–455 (1972)PubMedCrossRefGoogle Scholar
  5. COHEN, P., R.C. CHIN & C. KIDSON: Interactions of hormonal steroids with nucleic acids. II. Structural and thermodynamic aspects of binding. Biochemistry 8, 3603–3609 (1969)PubMedCrossRefGoogle Scholar
  6. COHEN, S.N. & K.L. YIELDING: Spectrophotometric studies of the interaction of chloroquine with DNA. J. Biol. Chem. 240, 3123–3131 (1965)PubMedGoogle Scholar
  7. CORCORAN, J.W. & F.E. HAHN (eds.): Antibiotics. III. Mechanism of Action of Antimicrobial and Antitumor Agents. Springer-Verlag, Berlin-Heidelberg-New York (1974).Google Scholar
  8. CRAWFORD, L.V. & M.J. WARING: Supercoiling of polyoma virus DNA measured by its interaction with ethidium bromide. J. Mol. Biol. 25, 23–30 (1967)PubMedCrossRefGoogle Scholar
  9. DAVIS, M., E.W. PARNELL & J. ROSENBAUM: Steroid amines. Part IV. 3,17-Diaminoandrostane derivatives. J. Chem. Soc. (C) 1967, 1045–1052Google Scholar
  10. FULLER, W. & M.J. WARING: A molecular model for the interaction of ethidium bromide with DNA. Ber. Bunsenges. Physik. Chem. 68, 805–808 (1964)Google Scholar
  11. GOLDBERG, I.H. & P.A. FRIEDMAN: Antibiotics and ‘nucleic acids. Ann. Rev. Biochem. 40, 775–810 (1971)PubMedCrossRefGoogle Scholar
  12. HAHN, F.E. (ed.): Antimalarials and nucleic acids. Progress in Molecular and Sub-Cellular Biology 2, 69–133 (1971)Google Scholar
  13. HIRSCHBERG, E.: Thiaxanthenones: Miracil D and hycanthone. In ‘Antibiotics. III. Mechanism of Action of Antimicrobial and Antitumor Agents’ (eds. J.W. CORCORAN & F.E. HAHN ), Springer-Verlag, Berlin-Heidelberg-New York (1974).Google Scholar
  14. LERMAN, L.S.: Structural considerations in the interaction of DNA and acridines. J. Mol. Biol. 3, 18–30 (1961)PubMedCrossRefGoogle Scholar
  15. LERMAN, L.S.: Acridine mutagens and DNA structure. J. Cell. and Comp. Physiol. 64, Suppl. 1, 1–18 (1964)CrossRefGoogle Scholar
  16. MOLINARI, G. & G.F. LATA: Interaction of steroids with some pyrimidine and purine derivatives. Arch. Biochem. Biophys. 96, 486–490 (1962)PubMedCrossRefGoogle Scholar
  17. MÜLLER, W., D.M. CROTHERS & M.J. WARING: A non-intercalating proflavine derivative. Eur. J. Biochem. 39, 223–234 (1973)PubMedCrossRefGoogle Scholar
  18. MUNCK, A., J.F. SCOTT & L.L. ENGEL: The interaction of steroid hormones and coenzyme components. Biochim. Biophys. Acta 26, 397–407 (1957)PubMedCrossRefGoogle Scholar
  19. NEWTON, B.A.: Chemotherapeutic compounds affecting DNA structure and function. Adv. Pharmacol. Chemother. 8, 149–184 (1970)PubMedCrossRefGoogle Scholar
  20. NEWTON, B.A.: Berenil. In ‘Antibiotics. III. Mechanism of Action of Antimicrobial and Antitumor Agents’ (eds. J.W. CORCORAN & F.E. HAHN ), Springer-Verlag, Berlin-H idelberg-New York (1974).Google Scholar
  21. PAOLETTI, J. & J.B. LE PECQ: The change of the torsion of the DNA helix caused by intercalation. I. A discussion of the two different possibilities, winding or unwinding. Biochimie 53, 969–972 (1971)PubMedCrossRefGoogle Scholar
  22. PIGRAM, W.J., W. FULLER & M.E. DAVIES: Unwinding the DNA helix by intercalation. J. Mol. Biol. 80, 361–365 (1973)PubMedCrossRefGoogle Scholar
  23. PIGRAM, W.J., W. FULLER & L.D. HAMILTON: Stereochemistry of intercalation: interaction of daunomycin with DNA. Nature New Biol. 235, 17–19 (1972)PubMedCrossRefGoogle Scholar
  24. REVET, B.M.J., M. SCHMIR & J. VINOGRAD: Direct determination of the superhelix density of closed circular DNA by viscometric titration. Nature New Biol. 229, 10–13 (1971)PubMedGoogle Scholar
  25. SEAMAN, A. & M. WOODBINE: The antibacterial activity of phenanthridine compounds. Brit. J. Pharmacol. 9, 265–270 (1954)PubMedGoogle Scholar
  26. SOBELL, H.M., S.C. JAIN, T.D. SAKORE & C.E. NORDMAN: Stereochemistry of actinomycinDNA binding. Nature New Biol. 231, 200–205 (1971)PubMedGoogle Scholar
  27. SZYBALSKI, W. & V.N. IYER: The mitomycins and porfiromycins. In ‘Antibiotics. I. Mechanism of Action’ (eds. D. GOTTLIEB & P.D. SHAW), Springer-Verlag, BerlinHeidelberg-New York, pp 211–245 (1967).Google Scholar
  28. WAKELIN, L.P.G. & M.J. WARING: The unwinding of circular DNA by phenanthridinium drugs: Structure-activity relations for the intercalation reaction. Mol. Pharmacol. 10, 544–561 (1974)PubMedGoogle Scholar
  29. WARING, M.J.: Complex formation between ethidium bromide and nucleic acids. J. Mol. Biol. 13, 269–282 (1965)PubMedCrossRefGoogle Scholar
  30. WARING, M.J.: Variation of the supercoils in closed circular DNA by binding of antibiotics and drugs: Evidence for molecular models involving intercalation. J. Mol. Biol. 54, 247–279 (1970)PubMedCrossRefGoogle Scholar
  31. WARING, M.J.: Inhibitors of nucleic acid synthesis. In ‘The Molecular Basis of Antibiotic Action’ (E.F. GALE, E. CUNDLIFFE, P.E. REYNOLDS, M.H. RICHMOND & M.J. WARING), Wiley, London, pp 173–277 (1972)Google Scholar
  32. WARING, M.J.: Studies with closed circular duplex DNA as a probe for conformational alterations. Studia Biophysica (Berlin) 40, 151–157 (1973a)Google Scholar
  33. WARING, M.J.: Interaction of indazole analogs of lucanthone and hycanthone with closed circular duplex DNA. J. Pharm. Exp. Ther. 186, 385–389 (1973b)Google Scholar
  34. WARING, M.J.: Ethidium and propidium. In ‘Antibiotics. III. Mechanism of Action of Antimicrobial and Antitumor Agents’ (eds. J.W. CORCORAN & F.E. HAHN ), Springer-Verlag, Berlin-Heidelberg-New York (1974a).Google Scholar
  35. WARING, M.J.: Stacking interactions. Chemistry and Industry, in press (1974b)Google Scholar
  36. WARING, M.J. & J.W. CHISHOLM: Uncoiling of bacteriophage PM2 DNA by binding of steroidal diamines. Biochim. Biophys. Acta 262, 18–23 (1972)PubMedGoogle Scholar
  37. WEINSTEIN, I.B. & E. HIRSCHBERG: Mode of action of Miracil D. Progress in Molecular and Subcellular Biology 2, 232–246 (1971)CrossRefGoogle Scholar
  38. WELLS, R.D. & J.E. LARSON: Studies on the binding of actinomycin D to DNA and DNA model polymers. J. Mol. Biol. 49, 319–342 (1970)PubMedCrossRefGoogle Scholar
  39. WOOLFE, G.: Trypanocidal action of phenanthridine compounds: Effect of changing the quaternary groups of known trypanocides. Brit. J. Pharmacol. 11, 330–333 (1956).PubMedGoogle Scholar
  40. Trypanocidal action of phenanthridine compounds: Further 2,7-diamino phenanthridinium compounds. Brit. J. Pharmacol. 11, 334–338 (1956)Google Scholar

Copyright information

© Springer-Verlag/Wien 1975

Authors and Affiliations

  • Michael Waring

There are no affiliations available

Personalised recommendations